These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33835414)
1. Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness. Franklin M; Enrique A; Palacios J; Richards D Qual Life Res; 2021 Sep; 30(9):2633-2647. PubMed ID: 33835414 [TBL] [Abstract][Full Text] [Related]
2. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index. Franklin M; Hunter RM; Enrique A; Palacios J; Richards D Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775 [TBL] [Abstract][Full Text] [Related]
3. Enabling QALY estimation in mental health trials and care settings: mapping from the PHQ-9 and GAD-7 to the ReQoL-UI or EQ-5D-5L using mixture models. Franklin M; Hernández Alava M Qual Life Res; 2023 Oct; 32(10):2763-2778. PubMed ID: 37314661 [TBL] [Abstract][Full Text] [Related]
4. Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A. Xu RH; Keetharuth AD; Wang LL; Cheung AW; Wong EL Eur J Health Econ; 2022 Mar; 23(2):165-176. PubMed ID: 34338898 [TBL] [Abstract][Full Text] [Related]
5. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients. Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789 [TBL] [Abstract][Full Text] [Related]
6. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637 [TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health. Crick K; Al Sayah F; Ohinmaa A; Johnson JA Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342 [TBL] [Abstract][Full Text] [Related]
8. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression. O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K; Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689 [TBL] [Abstract][Full Text] [Related]
9. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412 [TBL] [Abstract][Full Text] [Related]
10. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics. Crossman-Barnes CJ; Sach T; Wilson A; Barton G Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971 [TBL] [Abstract][Full Text] [Related]
11. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation. Wong CKH; Lang BHH; Yu HMS; Lam CLK Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296 [TBL] [Abstract][Full Text] [Related]
12. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA. Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280 [TBL] [Abstract][Full Text] [Related]
13. Examining the psychometric properties of a split version of the EQ-5D-5L anxiety/depression dimension in patients with anxiety and/or depression. Belay YB; Mihalopoulos C; Lee YY; Mulhern B; Engel L Qual Life Res; 2023 Jul; 32(7):2025-2036. PubMed ID: 36809437 [TBL] [Abstract][Full Text] [Related]
14. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review. Keetharuth AD; Hussain H; Rowen D; Wailoo A Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Yfantopoulos J; Chantzaras A; Kontodimas S Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371 [TBL] [Abstract][Full Text] [Related]
16. Validity of EQ-5D-5L in stroke. Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978 [TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the EQ-5D-5L in patients with major depression: factor analysis and Rasch analysis. Bilbao A; Martín-Fernández J; García-Pérez L; Mendezona JI; Arrasate M; Candela R; Acosta FJ; Estebanez S; Retolaza A J Ment Health; 2022 Aug; 31(4):506-516. PubMed ID: 33522336 [TBL] [Abstract][Full Text] [Related]
18. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study. Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M; J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744 [TBL] [Abstract][Full Text] [Related]
19. Validity of the EQ-5D-5L questionnaire among the general population of Poland. Młyńczak K; Golicki D Qual Life Res; 2021 Mar; 30(3):817-829. PubMed ID: 33099710 [TBL] [Abstract][Full Text] [Related]
20. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia. Michalowsky B; Hoffmann W; Xie F J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]